Viagra sales slow from 1998 launch, as some adverse reports take toll

Article Abstract:

Blockbuster anti-impotence drug Viagra from Pfizer Inc. holds the record for the most successful drug launch ever. As pent-up demand was met, patients started dying and having other adverse events. The FDA's Adverse Event Report was obtained under the Freedom of Information Act for this article. Continued sales are expected to be about $700 million per year in the U.S. and about $1.5 billion worldwide, in spite of adverse events.

Comment:

Sales of Viagra expected to slow after record launch

United States, Forecasts, trends, outlooks, Sales & consumption, Blood Vessel Relaxants, Care and treatment, Drugs, Pharmaceutical industry, Statistics, Abstract, Pfizer Inc., Impotence, PFE, Viagra (Medication), Cardiovascular agents

---

Tamoxifen's use for some women being questioned

Article Abstract:

A new study raises doubts about the results of a previous US study that confirmed the effectiveness of the tamoxifen anti-breast cancer drug. The US study determined that Tamoxifen protected high-risk women against breast cancer. However, scientists in Britain asserted that there was not enough evidence to show that Tamoxifen was an effective preventative drug for breast cancer.

Comment:

UK: New study raises doubts about the results of a US study confirming the effectiveness of the tamoxifen breast cancer drug

Research and Development in the Physical, Engineering, and Life Sciences, Science & research, Research Findings, Anticancer Drugs, Cancer & Cell R&D, Cancer research, Antineoplastic agents, Article

---

AstraZeneca's new ulcer drug shows some advantage

Article Abstract:

AstraZeneca PLC's new ulcer drug Nexium is a little moe effective than its other leading anti-ulcer brand Prilosec.

Product information, Antiulcer Preps ex Antacids, AstraZeneca PLC, AZN, Antiulcer agents

Similar abstracts:

• Abstracts: Getting to sleep away from home: travel time. Attorneys' rising political clout. Postal Service tackles competition
• Abstracts: Intraday futures volatility and theories of market behavior. A bivariate generalized autoregressive conditional heteroscedasticity-in-mean study of the relationship between return variability and trading volume in international futures markets
• Abstracts: R.H. Donnelley, split off from D&B, looks to Internet to protect yellow pages. Despite Net's growth, print Yellow Pages are profitable

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.